Regorafenib for Recurrent Meningioma (MIRAGE Trial)

Clinical trial NCT06275919 · RECRUITING

Trial details

NCT number: NCT06275919
Sponsor: Istituto Oncologico Veneto IRCCS
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Meningioma, Malignant

Start date: 2024-09-23
Primary completion: 2026-12-01
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.